About
Laguna Bio develops engineered microbial immunotherapies using its proprietary QUAIL platform to activate innate immune cells in vivo, aiming to treat various cancers including high-risk leukemias and solid tumors by overcoming immune evasion.
Explore Laguna Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.